Catalyst Pharmaceuticals Share Price Today
(NASDAQ: CPRX)

Name: Catalyst Pharmaceuticals Share Price Today (NASDAQ: CPRX) - Catalyst Pharmaceuticals Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Catalyst Pharmaceuticals share price is $21.4 & ₹1,845.43 as on 9 Apr 2025, 2.30 'hrs' IST

$21.4

▲

-0.41

(-1.88%)

Market is closed - opens 7 PM, 09 Apr 2025

View live Catalyst Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Catalyst Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Catalyst Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Catalyst Pharmaceuticals share price movements

Today's Low: $21.07
Today's High: $23.09
$21.40
1.54%
Downside
Day's Volatility :8.73%
Upside
7.3%
52 Weeks Low: $14.47
52 Weeks High: $26.16
$21.40
32.38%
Downside
52 Weeks Volatility :44.68%
Upside
18.19%

Catalyst Pharmaceuticals (CPRX) Returns

Period	Catalyst Pharmaceuticals Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-4.34%	-4.2%	0.0%
6 Months	9.21%	-12.3%	0.0%
1 Year	38.13%	-6.1%	0.0%
3 Years	171.95%	-5.9%	-11.3%

Catalyst Pharmaceuticals (CPRX) Key Statistics

in dollars & INR

Previous Close	$21.81
Open	$22.89
Today's High	$23.085
Today's Low	$21.07
Market Capitalization	$2.8B
Today's Volume	$1.9M
52 Week High	$26.158
52 Week Low	$14.47
Revenue TTM	$491.7M
EBITDA	$232.9M
Earnings Per Share (EPS)	$1.31
PE Ratio	17.61
Profit Margin	33.33%
Quarterly Earnings Growth YOY	0.41%
Return On Equity TTM	29.38%

How to invest in Catalyst Pharmaceuticals Stock (CPRX) from India?

It is very easy for Indian residents to invest directly in Catalyst Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Catalyst Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Catalyst Pharmaceuticals or CPRX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Catalyst Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Catalyst Pharmaceuticals shares which would translate to 0.040 fractional shares of Catalyst Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Catalyst Pharmaceuticals, in just a few clicks!

Returns in Catalyst Pharmaceuticals (CPRX) for Indian investors in Rupees

The Catalyst Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Catalyst Pharmaceuticals investment value today

Current value as on today

₹1,39,174

Returns

₹39,174

(+39.17%)

Returns from Catalyst Pharmaceuticals Stock

₹35,529 (+35.53%)

Dollar Returns

₹3,645 (+3.65%)

Indian investors sentiment towards Catalyst Pharmaceuticals (CPRX)

23%

Period: Mar 9, 2025 to Apr 8, 2025. Change in 30 Days versus previous period

Search interest for Catalyst Pharmaceuticals Stock from India on INDmoney has increased by 23% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Catalyst Pharmaceuticals

BlackRock Inc
15.99%
Vanguard Group Inc
6.94%
State Street Corp
4.77%
Deerfield Management Co
2.58%
Dimensional Fund Advisors, Inc.
2.48%
Pacer Advisors, INC.
2.43%

Analyst Recommendation on Catalyst Pharmaceuticals

Buy

92%Buy

7%Hold

0%Sell

Based on 13 Wall street analysts offering stock ratings for Catalyst Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 13 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Catalyst Pharmaceuticals Stock (CPRX)

What analysts predicted

Upside of 58.29%

Target:

$33.88

Current:

$21.40

Insights on Catalyst Pharmaceuticals Stock (Ticker Symbol: CPRX)

Price Movement
In the last 1 year, CPRX stock has moved up by 38.1%
Increasing Revenue
Revenue is up for the last 4 quarters, 98.50M → 141.82M (in $), with an average increase of 11.2% per quarter
Increasing Net Profit
Netprofit is up for the last 4 quarters, 23.27M → 55.93M (in $), with an average increase of 23.8% per quarter
CPRX vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 49.4% return, outperforming this stock by 11.3%
Price to Sales
ForCPRX every $1 of sales, investors are willing to pay $5.2, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $12.7 for every $1 of sales.

Catalyst Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Catalyst Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Catalyst Pharmaceuticals (CPRX) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Catalyst Pharmaceuticals Inc	5.52%	9.21%	38.13%	171.95%	400.23%
Regeneron Pharmaceuticals, Inc.	-23.1%	-43.41%	-39.32%	-20.71%	10.78%
Beone Medicines Ltd	-9.12%	-8.26%	43.19%	19.59%	48.5%
Vertex Pharmaceuticals Incorporated	-5.09%	1.41%	17.33%	68.83%	88.11%
Alnylam Pharmaceuticals, Inc.	-0.05%	-14.01%	49.42%	47.97%	95.74%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Catalyst Pharmaceuticals Inc	17.61	17.61	0.0	2.16	0.29	0.18	NA	6.02
Regeneron Pharmaceuticals, Inc.	14.95	14.95	0.91	41.99	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.45	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.3	18.04	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.83	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Catalyst Pharmaceuticals Inc	Buy	$2.8B	400.23%	17.61	33.33%
Regeneron Pharmaceuticals, Inc.	Buy	$62.7B	10.78%	14.95	31.07%
Beone Medicines Ltd	NA	$30.9B	48.5%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$122.0B	88.11%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$30.5B	95.74%	NA	-12.37%

About Catalyst Pharmaceuticals

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States. It offers Firdapse for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); Fycompa, a novel non-competitive selective antagonist at the postsynaptic ionotropic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptor that is used to treat focal onset seizures, as well as tonic-clonic seizures; Ruzurgi for the treatment of pediatric LEMS patients; and AGAMREE, a corticosteroid for the treatment of duchenne muscular dystrophy. The company has license agreements with BioMarin Pharmaceutical Inc.; and a collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.

Organization	Catalyst Pharmaceuticals
Employees	181
CEO	Mr. Richard John Daly M.B.A.
Industry	Health Technology

Management People of Catalyst Pharmaceuticals

Name	Title
Mr. Richard John Daly M.B.A.	President, CEO & Director
Dr. Steven R. Miller Ph.D.	Executive VP, COO & Chief Scientific Officer
Dr. Gary Ingenito M.D., Ph.D.	Chief Medical & Regulatory Officer
Mr. Jeffrey Del Carmen	Executive VP & Chief Commercial Officer
Mr. Michael W. Kalb CPA	Executive VP, Treasurer & CFO
Ms. Mary Coleman	VP & Head of Investor Relations
Mr. Brian Elsbernd J.D.	Chief Compliance Officer & Chief Legal Officer
Mr. Gregg Russo	Chief Human Resources Officer
Dr. Stanley Iyadurai M.D., Ph.D.	Senior Vice President of Medical Affairs & Drug Discovery
Dr. Preethi Sundaram Ph.D.	Chief Strategy Officer

Important FAQs about investing in CPRX Stock from India :

What is Catalyst Pharmaceuticals share price today?

Catalyst Pharmaceuticals share price today stands at $21.40, Open: $22.89 ; Previous Close: $21.81 ; High: $23.09 ; Low: $21.07 ; 52 Week High: $26.16 ; 52 Week Low: $14.47.

The stock opens at $22.89, after a previous close of $21.81. The stock reached a daily high of $23.09 and a low of $21.07, with a 52-week high of $26.16 and a 52-week low of $14.47.

Can Indians buy Catalyst Pharmaceuticals shares?

Yes, Indians can invest in the Catalyst Pharmaceuticals (CPRX) from India.

With INDmoney, you can buy Catalyst Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Catalyst Pharmaceuticals at zero transaction cost.

How can I buy Catalyst Pharmaceuticals shares from India?

It is very easy to buy Catalyst Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Catalyst Pharmaceuticals (CPRX) be purchased?

Yes, you can buy fractional shares of Catalyst Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Catalyst Pharmaceuticals stocks?

To start investing in Catalyst Pharmaceuticals, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.